ClinicalTrials.gov
ClinicalTrials.gov Menu

Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00327093
Recruitment Status : Terminated (The scientific commitee decided to stop the inclusions and exploit the results.)
First Posted : May 18, 2006
Last Update Posted : February 9, 2009
Sponsor:
Information provided by:
Hospices Civils de Lyon

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 2008
  Actual Study Completion Date : October 2008